Plain-English translation of NCT07653009 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a non-invasive treatment called transcutaneous auricular vagus nerve stimulation (taVNS), which uses gentle electrical pulses applied to specific spots on your ear. The goal is to see whether this treatment can reduce pain, inflammation, and disease activity in people with psoriatic arthritis — a condition where your immune system attacks both your skin and joints. Researchers believe this approach may help by activating a natural anti-inflammatory pathway in your body.
While existing arthritis medications work for many people, they don't work for everyone, can cause side effects, and may stop working over time. This trial exists to explore whether this medication offers a safer, non-invasive option that could reduce inflammation and improve quality of life for people with psoriatic arthritis.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic for a 10-day treatment period. During each session, small electrodes will be gently placed on your ear (specifically on the tragus and the inner curved part of your ear), and you'll receive mild electrical stimulation for 20 minutes. The researchers will measure your pain, inflammation markers in your blood, joint function, sleep quality, and mood before and after treatment to see if the stimulation helps.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Turkey (Türkiye)